As of 2025-09-16, the Relative Valuation of Krystal Biotech Inc (KRYS) is 110.71 USD. This relative valuation is based on P/E multiples. With the latest stock price at 155.71 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -28.9%.
The range of the Relative Valuation is 76.84 - 155.65 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.4x - 30.7x | 27.6x |
| Forward P/E multiples | 29.8x - 33.6x | 31.7x |
| Fair Price | 76.84 - 155.65 | 110.71 |
| Upside | -50.7% - -0.0% | -28.9% |
| Date | P/E |
| 2025-09-15 | 30.71 |
| 2025-09-12 | 28.34 |
| 2025-09-11 | 28.47 |
| 2025-09-10 | 27.11 |
| 2025-09-09 | 27.85 |
| 2025-09-08 | 28.64 |
| 2025-09-05 | 29.64 |
| 2025-09-04 | 29.54 |
| 2025-09-03 | 29.63 |
| 2025-09-02 | 29.39 |
| 2025-08-29 | 29.13 |
| 2025-08-28 | 29.74 |
| 2025-08-27 | 29.12 |
| 2025-08-26 | 28.97 |
| 2025-08-25 | 28.95 |
| 2025-08-22 | 29.68 |
| 2025-08-21 | 28.74 |
| 2025-08-20 | 28.77 |
| 2025-08-19 | 28.39 |
| 2025-08-18 | 28.86 |
| 2025-08-15 | 29.64 |
| 2025-08-14 | 29.65 |
| 2025-08-13 | 29.46 |
| 2025-08-12 | 28.33 |
| 2025-08-11 | 27.13 |
| 2025-08-08 | 27.35 |
| 2025-08-07 | 26.84 |
| 2025-08-06 | 26.82 |
| 2025-08-05 | 27.09 |
| 2025-08-04 | 26.62 |
| 2025-08-01 | 30.96 |
| 2025-07-31 | 30.35 |
| 2025-07-30 | 30.22 |
| 2025-07-29 | 30.00 |
| 2025-07-28 | 30.16 |
| 2025-07-25 | 29.11 |
| 2025-07-24 | 29.59 |
| 2025-07-23 | 30.23 |
| 2025-07-22 | 29.96 |
| 2025-07-21 | 29.21 |
| 2025-07-18 | 29.09 |
| 2025-07-17 | 29.62 |
| 2025-07-16 | 29.60 |
| 2025-07-15 | 29.14 |
| 2025-07-14 | 29.67 |
| 2025-07-11 | 29.23 |
| 2025-07-10 | 29.53 |
| 2025-07-09 | 29.37 |
| 2025-07-08 | 28.27 |
| 2025-07-07 | 27.56 |